Publisher Correction: Targeting hepatic glutaminase activity to ameliorate hyperglycemia

Russell A. Miller, Yuji Shi, Wenyun Lu, David A. Pirman, Aditi Jatkar, Matthew Blatnik, Hong Wu, César Cárdenas, Min Wan, J. Kevin Foskett, Junyoung O. Park, Yiyi Zhang, William L. Holland, Joshua D. Rabinowitz, Morris J. Birnbaum

Research output: Contribution to journalArticle

Abstract

In the version of this article initially published, the “[13C2]α-ketoglutarate” label on Fig. 1g is incorrect. It should be “[13C5]α-ketoglutarate”. Additionally, in Fig. 3b, the “AAV-GFP” group is missing a notation for significance, and in Fig. 3c, the “AAV-GLS2-sh” group is missing a notation for significance. There should be a double asterisk notating significance in both panels. Finally, in the Fig. 4g legend, “[13C6]UDP-glucose” should be “[13C3]UDP-glucose”, and in the Fig. 4h legend, “[13C6]hexose” should be “[13C3]hexose”. The errors have been corrected in the HTML and PDF versions of this article.

Original languageEnglish (US)
Number of pages1
JournalNature Medicine
DOIs
StateAccepted/In press - Jun 12 2018

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Publisher Correction: Targeting hepatic glutaminase activity to ameliorate hyperglycemia'. Together they form a unique fingerprint.

  • Cite this

    Miller, R. A., Shi, Y., Lu, W., Pirman, D. A., Jatkar, A., Blatnik, M., Wu, H., Cárdenas, C., Wan, M., Foskett, J. K., Park, J. O., Zhang, Y., Holland, W. L., Rabinowitz, J. D., & Birnbaum, M. J. (Accepted/In press). Publisher Correction: Targeting hepatic glutaminase activity to ameliorate hyperglycemia. Nature Medicine. https://doi.org/10.1038/s41591-018-0047-1